Sowell Financial Services LLC Hepion Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$1.56 - $2.26 $17,390 - $25,194	-11,148 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.77 - $2.98 $6,779 - $11,413	3,830 Added 52.34%	11,148 $18,000
Q4 2020 Jan 13, 2021	BUY	$1.58 - $3.64 $11,560 - $26,633	7,317 Added 731700.0%	7,318 $16,000
Q3 2020 Nov 12, 2020	SELL	$2.84 - $4.59 $11 - $18	-4 Reduced 80.0%	1 $0
Q2 2020 Aug 13, 2020	SELL	$1.31 - $3.09 $131 - $309	-100 Reduced 95.24%	5 $0
Q4 2019 Feb 07, 2020	BUY	$2.25 - $6.99 $222 - $692	99 Added 1650.0%	105 $0
Q3 2019 Nov 14, 2019	BUY	$2.09 - $4.12 $12 - $24	6 New	6 $0

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $45.7M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.